Patent · US Active

Compounds as cannabinoid receptor ligands

US8188135B2 · kind B2 · utility

0Cited by

16References

16Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

William A. Carroll · Evanston, US
Michael J. Dart · Highland Park, US
Jennifer M. Frost · Grayslake, US
Steven P. Latshaw · Round Lake, US
Teodozyj Kolasa · Lake Villa, US
Tongmei Li · Lake Bluff, US
Sridhar Peddi · Grayslake, US
Bo Liu · Beijing, CN
Arturo Perez-Medrano · Grayslake, US
Meena Patel · Libertyville, US
Xueqing Wang · Evanston, US
Derek W. Nelson · Troy, US

Key dates

Filing date	Sep 16, 2009
Grant date	May 29, 2012
Priority date	—
Expiry date	Feb 10, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are cannabinoid receptor ligands of formula (I)wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.